The use of dupilumab in difficult-to-treat areas of atopic dermatitis: lessons from real-world studies.

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease with a big impact on quality of life. Despite major therapeutic advances, the involvement of difficult-to-treat areas such as the head and neck, hands and feet, and genital regi…

Preview only. Read the full abstract at the source